loading page

Immunotherapy beyond cellular therapy in Follicular Lymphoma: A case of complete remission after failure of two CAR-T
  • +2
  • Adam Kase,
  • Mohamed Kharfan Dabaja ,
  • Andrew Donaldson,
  • Jamie Elliott,
  • Taimur Sher
Adam Kase
Mayo Clinic in Florida

Corresponding Author:[email protected]

Author Profile
Mohamed Kharfan Dabaja
Mayo Clinic Hospital Jacksonville
Author Profile
Andrew Donaldson
Mayo Clinic in Florida
Author Profile
Jamie Elliott
Mayo Clinic in Florida
Author Profile
Taimur Sher
Mayo Clinic in Florida
Author Profile

Abstract

Patients with relapsed follicular lymphoma who do not respond to CAR-T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR-T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising treatment option in the post-CAR-T setting.
13 Jan 2022Submitted to Clinical Case Reports
17 Jan 2022Submission Checks Completed
17 Jan 2022Assigned to Editor
30 Jan 2022Reviewer(s) Assigned
09 Feb 2022Review(s) Completed, Editorial Evaluation Pending
16 Feb 2022Editorial Decision: Accept
Apr 2022Published in Clinical Case Reports volume 10 issue 4. 10.1002/ccr3.5572